SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2012

SEGMENT INFORMATION

Information about reportable segments

The table below presents information about Edwards Lifesciences' reportable segments (in millions):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Segment Net Sales
United States	$	193.5	$	150.5	$	587.1	$	450.9
Europe		129.7		128.9		430.9		409.0
Japan		70.7		53.3		214.0		167.9
Rest of world		62.0		50.1		171.7		147.9
Total segment net sales	$	455.9	$	382.8	$	1,403.7	$	1,175.7
Segment Pre-Tax Income
United States	$	109.2	$	76.3	$	330.2	$	237.2
Europe		53.4		52.4		185.2		177.2
Japan		36.5		23.6		110.2		78.9
Rest of world		19.3		15.4		48.5		44.8
Total segment pre-tax income	$	218.4	$	167.7	$	674.1	$	538.1

Reconciliations of segment net sales to consolidated net sales and segment pre-tax income to consolidated pre-tax income

 The table below presents reconciliations of segment net sales to consolidated net sales and segment pre-tax income to consolidated pre-tax income (in millions):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
Net Sales Reconciliation
Segment net sales	$	455.9		$	382.8		$	1,403.7		$	1,175.7
Foreign currency		(8.0	)		29.9			(14.6	)		72.7
Consolidated net sales	$	447.9		$	412.7		$	1,389.1		$	1,248.4
Pre-Tax Income Reconciliation
Segment pre-tax income	$	218.4		$	167.7		$	674.1		$	538.1
Unallocated amounts:
Corporate items		(127.4	)		(109.8	)		(399.1	)		(330.2	)
Special charges		—			—			(7.0	)		(4.0	)
Interest income, net		0.3			—			0.4			0.3
Foreign currency		2.1			(0.3	)		0.5			10.8
Consolidated pre-tax income	$	93.4		$	57.6		$	268.9		$	215.0

Enterprise-wide information

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
	(in millions)
Net Sales by Geographic Area
United States	$	193.6	$	150.5	$	587.2	$	450.9
Europe		121.8		139.1		417.1		430.3
Japan		71.8		67.8		214.9		206.9
Rest of world		60.7		55.3		169.9		160.3
	$	447.9	$	412.7	$	1,389.1	$	1,248.4
Net Sales by Major Product and Service Area
Surgical Heart Valve Therapy	$	185.7	$	190.4	$	589.8	$	593.8
Transcatheter Heart Valves		123.8		82.6		391.1		240.6
Critical Care		138.4		139.7		408.2		414.0
	$	447.9	$	412.7	$	1,389.1	$	1,248.4

	September 30, 2012		December 31, 2011
	(in millions)
Long-Lived Tangible Assets by Geographic Area
United States	$	241.0	$	223.0
International		113.7		105.9
	$	354.7	$	328.9